Hexagon Capital Partners’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,266
Closed -$15.7K 1859
2024
Q3
$15.7K Buy
+2,266
New +$17.8K ﹤0.01% 790
2023
Q4
Sell
-327
Closed -$1.84K 1452
2023
Q3
$1.84K Buy
+327
New +$2.18K ﹤0.01% 1083

Other funds holding GDRX

Hexagon Capital Partners's GDRX Position: Q4 2024 in Review

Hexagon Capital Partners sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 2,266 shares — an estimated $15.7K sold.

Hexagon Capital Partners first reported a position in GDRX in Q3 2023 and held it in 2 quarters. The position peaked at $15.7K in Q3 2024. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Hexagon Capital Partners reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Hexagon Capital Partners sold 2,266 GoodRx Holdings shares in Q4 2024, an estimated $15.7K.
  • Hexagon Capital Partners first reported a position in GoodRx Holdings in Q3 2023 and held it in 2 quarters.
  • Hexagon Capital Partners's GoodRx Holdings position peaked at $15.7K in Q3 2024.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Hexagon Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.